≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

Endpoint Browser PheWeb

C3_HEPATOCELLU_CARC_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C22.0&
  • Cause of death: ICD-10 — C22.0&
  • Cancer registry: Topography ICD-O-3 — C22
  • Cancer registry: Morphology ICD-O-3 — 817[0-5]
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

982

4. Check minimum number of events

None

982

5. Include endpoints

None

982

6. Filter based on genotype QC (FinnGen only)

982

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

List of similar endpoints to Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 982 172 810
Unadjusted period prevalence (%) 0.30 0.06 0.36
Median age at first event (years) 72.05 71.92 72.08

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
635
Matched controls
6351
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8170/3-C22.0
ICD-O-3
Hepatocellular carcinoma, NOS, of liver
+∞
323.0
503
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
323.0
600
*
130
Kela drug reimbursment
Malignant tumour
+∞
312.0
273
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
287.2
231.9
224
12
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
252.5
222.3
217
13
198
Kela drug reimbursment
Sorafenib
+∞
170.7
156
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
+∞
146.7
135
*
Z51.5
ICD-10 Finland
Palliative care
29.7
131.7
181
84
8000/3-C22.0
ICD-O-3
Neoplasm, malignant of liver
+∞
120.8
112
*
L01XE05
ATC
[U] sorafenib; oral
+∞
119.6
111
*
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
62.1
118.3
137
28
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
14.2
105.0
191
186
A03FA01
ATC
metoclopramide; systemic, rectal
10.6
96.0
206
276
N02AA05
ATC
oxycodone; systemic
8.3
95.8
246
447
JN4CD
NOMESCO Finland
Very extensive body CT
36.0
95.0
123
42
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
24.6
84.1
121
60
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
73.4
69
*
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
48.9
70.4
85
20
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
67.9
64
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
352.0
63.6
63
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
62.5
59
*
323
Kela drug reimbursment
Sorafenib
+∞
61.5
58
*
PC2DT
NOMESCO Finland
Embolisation of lesion of liver
+∞
61.5
58
*
R18
ICD-10 Finland
Ascites
27.5
60.8
84
35
C03DA01
ATC
spironolactone; oral
5.3
57.2
205
523
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
15.7
57.2
96
71
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
25.2
55.2
78
35
JN4BD
NOMESCO Finland
Extensive body CT
9.1
53.8
120
158
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
36.1
52.9
68
21
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
40.7
52.8
66
18
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.5
49.5
165
380
Z94.4
ICD-10 Finland
Liver transplant status
+∞
47.5
45
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
18.6
46.8
73
44
JN4AD
NOMESCO Finland
Body CT examination
10.8
46.1
92
98
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
43.7
45.5
56
14
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
45.3
43
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.4
44.9
104
144
JJ6LT
NOMESCO Finland
Coagulation of focal hepatic lesion under ultrasound guidance
+∞
43.2
41
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.9
42.5
214
732
JJC00
NOMESCO Finland
Allogenic transplantation of liver
+∞
42.1
40
*
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
+∞
42.1
40
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.4
42.1
277
1172
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
10.5
40.8
82
88
WF002
NOMESCO Finland
Radical radiotherapy
+∞
38.9
37
*
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
70.9
35.4
40
6
A04AA02
ATC
granisetron; systemic, transdermal
355.1
34.3
34
*
116
Kela drug reimbursment
Prostate cancer
+∞
33.6
32
*
127
Kela drug reimbursment
Transplant complication
23.5
32.2
46
21
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
31.5
30
*
103
Kela drug reimbursment
Diabetes, insulin-treated
2.8
31.5
301
1556
A04AA01
ATC
ondansetron; systemic, rectal
19.1
31.5
48
27
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.9
31.1
111
265
3019
Kela drug reimbursment
Lenvatinib
+∞
30.5
29
*
L01EX02
ATC
sorafenib; oral
+∞
29.4
28
*
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
31.0
28.8
38
13
H02AB02
ATC
dexamethasone; systemic
21.3
28.6
42
21
N02AX02
ATC
tramadol; systemic, rectal
2.6
28.5
322
1798
C03CA01
ATC
furosemide; systemic
2.6
28.4
339
1953
1508
Kela drug reimbursment
Lenvatinib
+∞
28.3
27
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.7
28.1
264
1326
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
104.8
27.9
30
*
A10BA02
ATC
metformin; oral
2.6
27.8
295
1583
D77
ICPC
Malignant digestive neopl other/NOS
282.3
26.9
27
*
L04AA06
ATC
mycophenolic acid; systemic
16.6
26.3
42
27
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
+∞
25.2
24
*
I85.0
ICD-10 Finland
Oesophageal varices with bleeding
36.1
24.5
31
9
A06AD11
ATC
lactulose; oral
2.9
24.5
177
745
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
24.1
23
*
WZC30
NOMESCO Finland
Teaching
4.2
23.5
96
259
176
Kela drug reimbursment
Regorafenib
+∞
23.1
22
*
K92.0
ICD-10 Finland
Haematemesis
6.6
22.9
60
98
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
86.7
22.8
25
*
K76.9
ICD-10 Finland
Liver disease, unspecified
16.5
22.6
36
23
JN3AD
NOMESCO Finland
Abdominal CT examination
4.5
22.0
83
207
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
22.0
21
*
L01EX08
ATC
lenvatinib; oral
+∞
22.0
21
*
L02AE02
ATC
leuprorelin; implant, parenteral
227.4
21.7
22
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.4
21.3
66
133
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
37.1
20.0
25
7
A07AA11
ATC
rifaximin; oral
108.4
19.7
21
*
B01AB10
ATC
tinzaparin; parenteral
6.0
19.3
54
96
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
+∞
18.8
18
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.1
18.7
52
92
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
39.7
18.7
23
6
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
195.4
18.6
19
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.5
18.1
166
781
A05AA02
ATC
ursodeoxycholic acid; oral
17.2
18.0
28
17
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
17.8
162
760
C22
ICD-10 Finland
Malignant neoplasm of liver and intrahepatic bile ducts
+∞
17.8
17
*
JJ7LT
NOMESCO Finland
Coagulation of focal hepatic lesion under CT guidance
+∞
17.8
17
*
JJA44
NOMESCO Finland
Laparoscopic destruction of lesion of liver
+∞
17.8
17
*
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
9.5
17.6
36
40
A79
ICPC
Malignancy NOS
184.9
17.6
18
*
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.3
17.5
211
1138
T90
ICPC
Diabetes non-insulin dependent
2.3
17.4
207
1114
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
26.4
17.0
23
9
B01AB05
ATC
enoxaparin; parenteral
2.3
17.0
199
1059
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
65.1
16.8
19
*
UJF32
NOMESCO Finland
Coloscopy
2.4
16.8
179
908
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
16.7
16
*
JJB10
NOMESCO Finland
Atypcal resection of liver
+∞
16.7
16
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
16.7
16
*
JJB71
NOMESCO Finland
Laparoscopic resection of liver
+∞
16.7
16
*
JJ5AT
NOMESCO Finland
NA
+∞
16.7
16
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
16.7
16
*
JJB30
NOMESCO Finland
Excision of two segments of liver
+∞
16.7
16
*
A10AE04
ATC
insulin glargine; parenteral
2.9
16.7
110
425
L04AD01
ATC
ciclosporin; systemic
9.9
16.6
33
35
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
16.4
304
1967
A10BB12
ATC
glimepiride; oral
2.9
16.3
111
438
J01MA12
ATC
levofloxacin; systemic
2.5
16.1
152
722
B18.2
ICD-10 Finland
Chronic viral hepatitis C
25.2
16.1
22
9
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
+∞
15.7
15
*
A02BC02
ATC
pantoprazole; systemic
2.0
15.6
387
2786
WX402
NOMESCO Finland
General anaesthesia
3.1
15.6
89
313
JJ3AT
NOMESCO Finland
Cytology of liver with ultrasound guidance
163.8
15.5
16
*
D97
ICPC
Liver disease NOS
39.1
15.5
19
5
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
15.3
110
449
K92.1
ICD-10 Finland
Melaena
3.7
15.0
67
195
TPH07
NOMESCO Finland
Cathetrisation of artery
3.0
14.9
89
322
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
21.7
14.7
21
10
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
14.6
14
*
C22.7
ICD-10 Finland
Malignant neoplasm: Other specified carcinomas of liver
+∞
14.6
14
*
L01XE21
ATC
[U] regorafenib; oral
+∞
14.6
14
*
L02BB03
ATC
bicalutamide; oral
153.3
14.5
15
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
5.6
14.2
41
77
A10BH01
ATC
sitagliptin; oral
2.7
13.9
101
411
I81
ICD-10 Finland
Portal vein thrombosis
30.8
13.9
18
6
JN3GE
NOMESCO Finland
Intraoperative ultrasound examination of abdomen
+∞
13.6
13
*
PC2SC
NOMESCO Finland
Liver angiography with X-ray
+∞
13.6
13
*
369
Kela drug reimbursment
Regorafenib
+∞
13.6
13
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
13.6
13
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
34.8
13.6
17
5
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.6
13.5
103
434
K72.1
ICD-10 Finland
Chronic hepatic failure
26.4
13.4
18
7
TK800
NOMESCO Finland
Hemodialysis
6.1
13.3
36
62
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.4
13.2
48
116
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
8.6
13.1
28
34
KCD02
NOMESCO Finland
Transurethral resection of bladder
17.2
13.0
20
12
WW500
NOMESCO Finland
Blood transfusion
6.2
12.9
34
57
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.2
12.7
142
725
J01MA02
ATC
ciprofloxacin; systemic
1.9
12.6
264
1732
D13.4
ICD-10 Finland
Benign neoplasm: Liver
32.7
12.6
16
5
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
+∞
12.5
12
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
12.5
12
*
C07AA05
ATC
propranolol; systemic
2.6
12.5
97
413
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.8
12.2
82
319
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
16.3
12.2
19
12
SPAT1262
SPAT
Handing over of treatment supplies
2.1
12.0
152
820
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
+∞
11.5
11
*
TJA10
NOMESCO Finland
Laparocentesis
122.1
11.5
12
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
122.1
11.5
12
*
R4110
NOMESCO Finland
Physiotherapy
2.0
11.4
161
906
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
11.2
95
423
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.7
10.8
36
80
R50.9
ICD-10 Finland
Fever, unspecified
2.4
10.8
99
457
L01XE29
ATC
[U] lenvatinib; oral
+∞
10.4
10
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
10.4
10
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
10.4
10
*
JJA20
NOMESCO Finland
Open biopsy of liver
33.1
10.4
13
*
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
9.0
10.3
21
24
R4190
NOMESCO Finland
Nutritional therapy
9.3
10.1
20
22
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
40.7
10.0
12
*
205
Kela drug reimbursment
Chronic hypertension
1.7
9.7
265
1853
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.9
9.7
39
105
C10AA05
ATC
atorvastatin; oral
0.5
9.7
131
2065
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
5.6
9.6
27
50
K83.0
ICD-10 Finland
Cholangitis
6.3
9.5
24
39
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
101.4
9.4
10
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.2
9.4
102
510
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
30.5
9.4
12
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
12.6
9.4
16
13
JJB20
NOMESCO Finland
Excision of single segment of liver
+∞
9.4
9
*
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
+∞
9.4
9
*
1550A
ICD-9 Finland
Malignant neoplasm of liver and intrahepatic bile ducts, Liver, primary
+∞
9.4
9
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
9.4
9
*
JJA43
NOMESCO Finland
Destruction of lesion of liver
+∞
9.4
9
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
6.6
9.3
23
36
Z2446
NOMESCO Finland
Social worker
3.4
9.3
44
136
ZXE40
NOMESCO Finland
More than seven and less than nine hours
5.0
9.1
28
58
PC1BC
NOMESCO Finland
Extensive angiography of aorta and abdominal arteries
15.9
9.1
14
9
XX4BW
NOMESCO Finland
NA
24.4
8.9
12
5
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
8.9
130
734
A10AE05
ATC
insulin detemir; parenteral
2.8
8.8
58
223
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
50.7
8.7
10
*
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.2
8.6
86
415
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
8.6
112
606
ZXC40
NOMESCO Finland
Use of ultrasound
27.9
8.5
11
*
ZX120
NOMESCO Finland
Intravenous
2.8
8.5
55
211
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
8.3
8
*
K74.0
ICD-10 Finland
Hepatic fibrosis
+∞
8.3
8
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
8.3
8
*
L01EX05
ATC
regorafenib; oral
+∞
8.3
8
*
K70.4
ICD-10 Finland
Alcoholic hepatic failure
14.7
8.2
13
9
A98
ICPC
Health maint/preventive medicine
0.6
8.2
374
4461
SPAT1109
SPAT
Analgesia with portable analgesic pump
33.8
8.1
10
*
N02AA01
ATC
morphine; systemic, rectal
9.1
8.1
16
18
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
6.0
8.0
21
36
N05CF01
ATC
zopiclone; oral
1.7
8.0
205
1388
E66.00
ICD-10 Finland
Metabolic syndrome
3.0
7.9
43
148
A10BG03
ATC
pioglitazone; oral
3.7
7.9
33
93
UJK02
NOMESCO Finland
ERCP
4.4
7.8
27
64
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.5
7.7
35
105
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
7.7
171
1107
XF612
NOMESCO Finland
Measurement of central venous pressure
45.5
7.7
9
*
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
4.0
7.6
29
75
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
6.8
7.6
18
27
A06AH03
ATC
naloxegol; oral
18.6
7.6
11
6
L04AX01
ATC
azathioprine; systemic
3.8
7.6
30
81
K83.1
ICD-10 Finland
Obstruction of bile duct
7.2
7.5
17
24
ZX050
NOMESCO Finland
Stereotactic radiotherapy
81.0
7.4
8
*
K70.1
ICD-10 Finland
Alcoholic hepatitis
9.5
7.3
14
15
JJB40
NOMESCO Finland
Excision of segments II, III and IV of liver
+∞
7.3
7
*
L01BC06
ATC
capecitabine; oral
+∞
7.3
7
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
7.3
7
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
7.3
7
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
7.3
7
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
7.3
7
*
K70.2
ICD-10 Finland
Alcoholic fibrosis and sclerosis of liver
+∞
7.3
7
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
7.3
7
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
7.3
7
*
JAH00
NOMESCO Finland
Laparotomy
4.4
7.3
25
59
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.8
7.3
44
163
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
7.2
35
780
N06DX01
ATC
memantine; oral
0.3
7.2
11
414
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
30.4
7.2
9
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
30.4
7.2
9
*
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
7.1
29
691
UJF30
NOMESCO Finland
Ileoscopy through colon
2.5
7.1
55
232
K70.0
ICD-10 Finland
Alcoholic fatty liver
7.1
7.0
16
23
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.1
7.0
79
403
UJD02
NOMESCO Finland
Gastroscopy
2.9
6.9
41
150
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
14.0
6.9
11
8
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
14.0
6.9
11
8
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
11.1
6.8
12
11
K76.89
ICD-10 Finland
Other specified diseases of liver
22.8
6.7
9
*
XQ902
NOMESCO Finland
Other photography
22.8
6.7
9
*
WX882
NOMESCO Finland
High dependency care
3.8
6.6
26
70
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.4
6.5
31
692
K76.6
ICD-10 Finland
Portal hypertension
70.5
6.4
7
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
70.5
6.4
7
*
Y77
ICPC
Malignant neoplasm prostate
70.5
6.4
7
*
WW200
SPAT
NA
0.2
6.4
5
276
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.7
6.3
41
159
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.9
6.3
36
128
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
18.2
6.3
9
5
C22.2
ICD-10 Finland
Malignant neoplasm: Hepatoblastoma
+∞
6.3
6
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
6.3
6
*
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
+∞
6.3
6
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
6.3
6
*
K76.7
ICD-10 Finland
Hepatorenal syndrome
26.9
6.2
8
*
A10BD07
ATC
metformin and sitagliptin; systemic
2.7
6.2
40
154
K72.9
ICD-10 Finland
Hepatic failure, unspecified
12.7
6.1
10
8
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.0
6.1
33
115

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
517
382
27.47
307.65
4.2
1.4
ug/l
4.5
3.8
0.25
451
290
(40768441) Liver Pathology biopsy report
227
19
155.09
307.65
1.9
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
288
176
22.74
307.65
5.2
2.2
umol/l
43.5
34.6
2.81
255
150
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
376
132
45.54
307.65
4.1
1.9
u/ml
206.5
105.2
0.33
338
103
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
451
559
14.07
307.65
6.0
1.9
g/l
0.2
0.2
7.01
427
491
(3007566) Smooth muscle Ab [Titer] in Serum
235
157
19.36
276.70
1.6
1.1
titre
64.4
85.8
0.39
16
12
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
179
74
29.36
258.78
1.4
1.0
g/l
1.6
1.6
0.71
174
63
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
411
691
9.51
257.32
12.2
2.5
umol/l
16.8
10.3
2.46
391
600
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
182
80
27.70
257.18
2.5
1.6
u/ml
82.4
57.0
0.29
173
70
(4035726)
234
198
15.20
240.62
1.6
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
315
468
9.44
215.79
1.7
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
304
461
9.10
203.90
1.7
1.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
92
11
92.18
175.30
5.0
3.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
343
694
7.06
174.25
12.7
6.4
mmol/l
8.7
11.5
8.21
330
647
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
94
43
24.07
129.07
1.5
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
280
641
5.71
121.00
2.5
1.8
%
1.6
1.7
0.22
250
525
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
73
19
41.43
119.96
4.5
2.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
521
1993
4.44
117.57
13.8
2.6
u/l
64.0
36.0
6.84
508
1874
(3033658) Prothrombin time (PT) actual/Normal
466
1663
4.43
115.14
17.3
3.7
%
73.2
80.5
8.18
456
1609
(3024561) Albumin [Mass/volume] in Serum or Plasma
651
3028
4.41
109.63
17.2
3.8
g/l
31.8
34.9
31.25
629
2752
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
65
18
38.60
104.92
2.2
2.0
e6/l
971.4
94862.0
0.47
41
11
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
119
124
10.78
104.25
1.2
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
185
336
6.55
101.08
1.8
1.3
g/l
1.7
1.2
2.35
169
301
(3033799) Differential panel - Peritoneal fluid
61
16
40.58
99.80
2.1
2.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
679
3396
4.24
99.67
25.5
3.9
umol/l
24.1
13.2
10.78
664
3179
(3021879) Hepatitis B virus core Ab [Presence] in Serum
161
262
7.15
97.71
1.4
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
59
15
41.78
97.25
1.2
4.3
—
—
—
0
0
(3024471) HLA-A [Type]
60
18
35.44
94.61
1.0
1.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
323
999
4.33
94.11
2.8
2.5
%
25.5
22.6
2.02
294
830
(3012095) Magnesium [Moles/volume] in Serum or Plasma
331
1050
4.25
93.05
4.9
2.7
mmol/l
0.8
0.8
12.05
318
957
(3024932) HLA-DR beta [Type]
59
18
34.81
92.56
1.0
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
196
414
5.67
90.94
2.2
2.0
g/l
13.9
11.2
9.50
182
371
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
123
163
8.48
89.28
5.2
3.0
mg/l
1.7
1.7
0.05
114
142
(44816559) Phosphatidylethanol [Mass/volume] in Blood
105
116
10.02
87.88
2.5
1.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
324
1060
4.07
86.49
2.7
2.4
g/l
2.3
2.2
1.33
305
968
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
70
41
18.31
85.81
2.3
2.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
220
539
4.97
85.73
4.4
2.2
u/l
31.7
34.6
0.53
196
433
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
69
41
18.03
83.97
1.2
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
75
54
14.95
82.61
1.3
1.3
titre
180.9
209.0
—
11
10
(3044007) Cell count panel - Peritoneal fluid
53
17
32.90
81.80
2.1
2.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
625
3281
3.49
77.85
19.2
11.9
inr
1.3
1.4
2.55
157
915
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
83
81
11.10
75.69
1.3
1.4
u/ml
111.3
110.6
—
6
12
(3022948) Iron [Moles/volume] in Serum or Plasma
325
1160
3.69
75.03
2.8
2.4
umol/l
13.7
12.6
1.51
311
1047
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
254
781
4.04
72.70
3.2
2.7
u/l
238.6
241.0
0.11
248
721
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
82
86
10.31
71.03
1.2
1.2
u/ml
360.9
250.3
1.66
55
46
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
469
2160
3.24
70.92
5.6
2.3
u/l
59.6
58.9
0.12
455
1974
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
85
94
9.80
70.83
1.3
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
441
2003
3.18
67.57
4.2
2.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
84
98
9.28
67.17
1.2
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
83
102
8.80
63.67
10.2
5.4
iu/ml
780.6
501.1
0.27
32
14
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
368
1556
3.18
62.96
4.1
2.2
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
43
17
26.41
61.76
1.9
1.2
g/l
9.0
12.1
—
29
10
(3002256) Pathology report gross observation
173
468
4.27
58.17
1.4
1.1
—
—
—
0
0
(4281824)
45
25
18.82
56.25
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
86
131
7.10
54.75
1.2
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
72
90
8.55
54.37
1.2
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
49
37
13.89
52.26
1.2
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
48
35
14.37
52.21
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
48
35
14.37
52.21
1.1
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
34
11
31.98
52.00
1.1
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
535
2999
2.72
51.52
7.1
3.7
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
50
43
12.20
49.28
1.0
1.0
mg/l
272.3
287.8
0.48
44
38
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
34
13
27.06
49.24
1.1
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
253
977
3.14
48.98
7.8
5.2
mmol/l
1.0
1.0
0.60
238
884
(3000991) Gas panel - Venous blood
194
687
3.27
43.01
10.3
7.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
585
3624
2.52
42.92
15.1
6.0
e9/l
4.0
4.5
5.45
533
3106
(3023368) Bacteria identified in Blood by Culture
422
2251
2.53
42.86
6.1
4.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
201
733
3.19
42.38
1.6
1.3
titre
288.0
476.3
1.80
45
174
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
42
36
12.14
41.41
1.2
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
385
2045
2.45
38.55
6.3
3.2
ph
7.4
7.4
0.06
80
361
(3014111) Lactate [Moles/volume] in Serum or Plasma
183
679
3.08
37.13
9.2
6.7
mmol/l
1.8
1.5
1.54
174
644
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
614
4051
2.38
36.77
13.4
3.0
u/l
201.7
53.4
37.41
590
3657
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
137
433
3.51
36.10
10.9
9.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
208
852
2.83
35.14
1.4
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
165
602
3.09
34.31
1.4
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
553
3566
2.26
33.87
11.0
5.7
mmol/l
1.2
1.2
9.13
475
2988
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
87
209
4.47
33.60
1.9
1.7
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
54
84
6.74
33.54
1.1
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
346
1853
2.34
32.98
2.5
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
102
282
3.92
32.64
2.6
2.7
u/ml
0.2
0.3
3.20
51
165
(3042936) Bacteria identified in Isolate by Culture
234
1059
2.59
32.22
2.8
2.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
245
1146
2.52
31.38
3.3
2.8
e6/l
1.2
1.3
0.11
145
640
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
513
3281
2.18
31.15
10.2
5.3
mmol/l
1.2
1.2
7.51
493
2890
(3002032) Base excess in Venous blood by calculation
195
820
2.72
31.03
4.2
3.3
mmol/l
0.8
2.0
4.37
151
644
(42870588) Differential panel, method unspecified - Blood
384
2199
2.23
30.72
7.3
5.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
296
1522
2.35
30.64
11.9
4.6
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
194
822
2.69
30.36
4.1
3.3
kpa
5.5
5.9
4.43
189
786
(3027801) Oxygen [Partial pressure] in Arterial blood
219
987
2.57
30.23
9.8
6.8
kpa
12.7
11.2
4.78
212
937
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
219
987
2.57
30.23
9.8
6.8
kpa
5.0
5.1
1.23
212
940
(3030467) Casts [#/volume] in Urine by Automated count
354
1985
2.22
29.61
4.2
3.0
e6/l
1.1
0.4
2.26
285
1502
(3003396) Base excess in Arterial blood by calculation
217
985
2.54
29.44
9.7
6.8
mmol/l
0.1
1.3
4.67
181
752
(3016650) Hepatitis A virus Ab [Presence] in Serum
52
89
6.11
29.41
1.1
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
341
1891
2.23
29.25
4.2
3.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
202
891
2.60
29.06
10.2
7.1
%
96.4
94.7
3.09
197
856
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
249
1214
2.41
28.87
3.2
2.6
e6/l
0.8
1.0
1.08
150
702
(3013826) Glucose [Moles/volume] in Serum or Plasma
619
4366
2.13
27.90
13.3
4.7
mmol/l
7.7
7.0
8.67
599
4103
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
28
24
11.98
27.47
3.4
2.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
211
979
2.47
27.12
1.8
1.2
g/l
4.4
2.9
10.64
176
553
(3002582) Erythrocytes [#/volume] in Urine
374
2210
2.12
26.81
4.4
3.1
e6/l
77.8
123.0
0.52
301
1711
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
144
573
2.77
25.20
3.8
2.3
ml/min/173m2
66.3
61.1
0.59
69
230
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
27
25
11.08
25.19
2.0
1.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
464
3057
1.98
23.88
8.8
5.7
%
9.6
9.0
2.70
439
2810
(3002030) Lymphocytes/100 leukocytes in Blood
468
3108
1.97
23.38
8.6
5.5
%
23.5
25.6
3.63
441
2840
(3022096) Basophils/100 leukocytes in Blood
450
2954
1.97
23.21
8.6
5.4
%
0.6
0.6
0.58
423
2715
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
690
5245
2.06
23.20
28.1
5.3
u/l
152.2
78.0
45.42
670
4809
(3006504) Eosinophils/100 leukocytes in Blood
460
3044
1.96
23.16
8.5
5.4
%
2.7
3.0
1.76
436
2789
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
170
764
2.48
23.14
4.2
3.3
—
—
—
0
0
(3026782) Osmolality of Urine
266
1447
2.15
23.07
3.5
2.6
mosm/kgh2o
562.4
567.5
0.15
242
1214
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
35
52
6.94
22.63
1.0
1.0
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
490
3330
1.94
22.63
8.3
5.2
e9/l
1.5
1.8
9.89
431
2871
(3001604) Monocytes [#/volume] in Blood
482
3260
1.94
22.55
8.4
5.1
e9/l
0.6
0.6
0.92
419
2764
(3006315) Basophils [#/volume] in Blood
483
3278
1.93
22.28
8.4
5.1
e9/l
0.0
0.0
2.61
419
2785
(3013115) Eosinophils [#/volume] in Blood
491
3377
1.91
21.49
8.7
5.2
e9/l
0.2
0.2
3.29
432
2916
(3018095) Leukocytes [#/volume] in Urine
392
2511
1.93
21.24
5.0
3.5
e6/l
74.9
116.7
0.73
311
1828
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
125
504
2.70
21.19
1.8
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
457
3083
1.90
21.11
8.3
5.4
%
60.3
58.9
1.56
433
2840
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
26
31
8.59
20.21
1.6
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
32
49
6.72
20.11
1.0
1.1
u/l
56.3
51.8
0.15
24
33
(3015377) Calcium [Moles/volume] in Serum or Plasma
348
2182
1.92
19.79
6.5
2.0
mmol/l
2.3
2.3
1.96
325
1761
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
236
1293
2.09
19.71
6.5
2.1
mmol/l
2.5
2.4
9.21
221
1082
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
400
2629
1.88
19.65
4.4
3.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
389
2601
1.82
17.59
3.9
2.8
ug/l
179.4
164.3
0.50
365
2343
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
309
1945
1.86
16.84
2.8
2.3
mg/l
3.7
3.0
4.18
271
1628
(3000850) Epithelial cells [#/volume] in Urine
258
1533
1.93
16.80
3.6
2.4
e6/l
5.4
3.8
1.36
243
1335
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
38
86
4.56
15.76
1.2
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
580
4540
1.68
13.68
5.1
4.3
e6/l
524.4
2708.9
—
8
90
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
218
1315
1.85
13.18
2.0
1.8
—
—
—
0
0
(3022145) Colonoscopy Study observation
121
595
2.18
13.04
1.5
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
253
1615
1.76
12.60
1.6
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
381
2722
1.65
12.47
4.4
4.0
mg/mmol
10.0
7.6
0.74
274
1817
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
112
554
2.15
11.87
4.9
3.0
mmol/l
1.2
1.2
0.87
105
469
(3024980) IgG subclass 4 [Mass/volume] in Serum
33
84
4.03
11.81
2.0
1.7
g/l
0.6
1.1
1.64
23
66
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
253
3646
0.59
11.70
3.5
3.9
%
24.7
24.1
0.17
103
1820
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
20
33
6.17
11.69
1.6
1.4
u/l
6.9
7.0
0.01
13
14
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
165
945
1.90
11.62
2.0
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
217
1353
1.78
11.61
1.9
1.7
mg/l
2.9
1.4
3.40
183
1048
(3052851) Hemolysis interference index of Serum or Plasma
56
203
2.86
11.56
4.2
3.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
363
2611
1.62
11.30
3.6
3.2
mmol/l
7.3
7.9
2.31
300
2186
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
164
946
1.88
11.28
2.0
1.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
208
1297
1.77
11.08
20.3
30.1
inr
1.5
1.5
0.10
18
182
(3035637) Corticotropin [Mass/volume] in Plasma
24
50
4.90
11.00
1.5
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
296
2035
1.65
10.98
3.2
3.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
63
257
2.55
10.37
3.9
2.4
g/l
0.2
0.2
0.00
44
92
(3012516) Albumin [Mass/volume] in Urine
350
2577
1.56
9.47
3.5
3.3
mg/l
541.7
192.5
0.66
260
1730
(3000494) Fungus identified in Specimen by Culture
134
772
1.85
9.18
1.9
1.4
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
116
638
1.93
9.16
2.7
1.6
g/l
66.3
66.7
0.17
104
564
(3012501) Base excess in Blood by calculation
46
173
2.74
8.91
6.2
4.6
mmol/l
1.8
2.5
1.75
31
112
(3010421) pH of Blood
51
203
2.60
8.85
6.2
4.4
ph
7.4
7.4
0.28
44
169
(1616796) Gas panel - Central venous blood
45
172
2.69
8.46
4.2
3.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
17
33
5.22
8.43
2.1
2.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
592
6817
0.67
8.29
6.0
4.8
mmol/l
4.0
4.3
8.82
539
6214
(3037467) Urinalysis macro (dipstick) panel - Urine
572
4755
1.49
8.28
5.2
4.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
93
491
1.99
8.26
1.6
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
20
675
0.28
8.24
1.4
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
381
2924
1.50
8.21
20.5
8.8
e9/l
0.0
0.0
0.90
306
2368
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
139
837
1.77
8.21
2.7
3.2
ng/l
225.0
275.6
0.84
128
781
(3027945) Reticulocytes/100 erythrocytes in Blood
163
1034
1.69
7.98
2.5
2.0
%
1.9
1.7
1.31
149
898
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
602
6892
0.67
7.97
5.7
5.0
mmol/l
6.8
6.2
13.40
537
6159
(3026493) Urate [Moles/volume] in Serum or Plasma
277
2000
1.54
7.93
4.3
2.6
umol/l
4239.2
7751.5
0.60
244
1686
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
76
379
2.09
7.89
1.6
1.6
g/l
1.1
1.5
2.08
62
320
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
170
2509
0.61
7.82
2.5
2.7
ug/l
0.9
0.8
0.82
110
1748
(3007853) Bacteria identified in Skin by Aerobe culture
140
858
1.74
7.76
1.6
1.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
15
28
5.42
7.74
1.9
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
617
7017
0.68
7.73
6.2
5.5
mmol/l
2.3
2.5
6.73
556
6353
(40760892) CBC W Ordered Manual Differential panel - Blood
193
1298
1.61
7.49
5.5
3.9
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
72
363
2.06
7.27
6.4
4.3
%
0.9
0.9
0.05
66
346
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
591
6745
0.69
7.19
5.9
4.8
mmol/l
1.2
1.4
16.87
531
6096
(3051611) Lipemic interference index of Serum or Plasma
21
57
3.74
6.94
3.2
3.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
10
6
16.82
6.75
1.0
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
104
611
1.79
6.66
6.2
4.7
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
36
140
2.63
6.60
1.3
1.4
mmol/l
58.8
65.5
0.36
24
111
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
365
4491
0.70
6.49
4.1
4.0
ug/l
2.1
2.2
0.12
301
3994
(3017181) Myelocytes/100 leukocytes in Blood
90
510
1.84
6.49
5.4
3.7
%
0.8
0.7
0.10
33
135
(3036481) Cortisol [Moles/volume] in Serum or Plasma
95
551
1.80
6.35
3.4
1.7
nmol/l
396.6
363.9
0.81
88
491
(3000570) Elastase.pancreatic [Mass/mass] in Stool
39
161
2.48
6.34
1.2
1.4
ug/g
328.9
282.1
0.75
22
97
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
228
1647
1.50
6.33
4.0
4.2
ng/l
447.1
487.2
0.08
202
1439
(3008152) Bicarbonate [Moles/volume] in Arterial blood
99
582
1.78
6.33
8.7
6.9
mmol/l
23.2
24.6
2.56
94
541
(40768795) Lymph node Pathology biopsy report
10
15
6.72
6.32
1.0
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
575
6525
0.71
6.09
5.4
4.3
mmol/l
1.4
1.3
2.13
517
5848
(3025941) Bacteria identified in Stool by Culture
58
296
2.02
5.71
1.2
1.3
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
84
486
1.80
5.68
5.6
3.8
%
0.1
0.1
0.01
32
122
(3047181) Lactate [Moles/volume] in Blood
54
273
2.03
5.47
7.6
5.6
mmol/l
2.2
1.3
1.24
47
246
(3002179) Metamyelocytes/100 leukocytes in Blood
79
455
1.80
5.43
4.9
3.7
%
0.5
0.5
0.03
24
95
(40760888) Immunoglobulin light chains.free panel - Serum
41
187
2.24
5.38
2.4
1.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
25
90
2.82
5.33
3.2
3.1
%
2.5
1.3
0.50
18
60
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
83
490
1.76
5.25
1.8
1.6
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
5
0
+∞
5.21
1.0
0.0
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
49
244
2.06
5.18
2.6
1.5
mg/l
34.0
39.2
0.57
37
198
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
35
152
2.35
5.15
1.6
1.5
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
49
245
2.05
5.12
2.6
1.5
mg/l
50.3
49.1
0.06
37
198
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
13
31
4.24
5.10
1.3
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
13
31
4.24
5.10
1.3
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
27
104
2.64
5.09
1.6
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
77
455
1.75
4.87
5.8
3.8
%
0.0
0.9
0.55
26
100
(1761868) Lipid panel - Serum or Plasma
146
2031
0.67
4.75
4.3
3.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
17
53
3.25
4.63
1.2
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
29
122
2.42
4.60
1.3
1.4
u/l
8.6
6.5
0.78
19
100
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
50
264
1.94
4.52
2.2
2.3
ug/min
147.6
102.8
0.30
34
165
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
327
2656
1.35
4.46
2.8
3.2
ng/l
1261.4
1820.0
1.15
284
2299
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
20
71
2.85
4.41
1.8
1.6
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
42
211
2.03
4.37
3.1
1.4
g/l
0.0
0.0
0.00
34
188
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
44
225
2.00
4.37
1.3
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
44
225
2.00
4.37
3.0
1.4
g/l
0.1
0.0
0.56
36
202
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
40
198
2.06
4.33
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
40
198
2.06
4.33
1.6
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
20
72
2.81
4.30
1.3
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
36
172
2.13
4.27
3.5
2.5
%
14.9
16.5
0.91
13
95
(3028308) Erythrocytes [#/volume] in Pleural fluid
24
97
2.51
4.15
1.9
1.5
e6/l
32751.3
93580.5
0.47
18
59
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
31
141
2.24
4.15
1.6
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
31
142
2.22
4.09
1.5
1.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
24
98
2.49
4.07
3.0
2.9
%
55.2
59.4
0.89
24
98
(3045788) Cell count panel - Pleural fluid
22
86
2.59
4.07
2.2
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
114
779
1.52
4.07
2.2
2.1
e9/l
76.3
67.2
1.45
83
605
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
7
7
10.06
4.01
1.4
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
20
75
2.70
4.01
2.1
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
85
549
1.60
3.88
2.4
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
26
113
2.34
3.87
1.2
1.6
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
40
207
1.97
3.87
3.2
1.4
g/l
0.0
0.0
0.00
33
187
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
154
1129
1.43
3.86
1.2
1.2
u/ml
1.5
1.5
0.04
28
303
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
37
187
2.02
3.82
1.4
1.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
23
96
2.43
3.75
2.9
2.7
e9/l
3.5
4.7
1.83
23
96
(4094501)
5
196
0.25
3.56
1.0
1.1
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
54
317
1.74
3.55
4.9
4.4
mmol/l
2.1
1.5
0.97
54
310
(3019309) Folate [Moles/volume] in Red Blood Cells
217
1710
1.35
3.52
1.9
1.8
nmol/l
1110.5
1165.4
0.38
163
1301
(40768446) Kidney Pathology biopsy report
8
13
6.19
3.50
1.0
2.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
6
10.05
3.50
1.0
1.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
611
6668
0.78
3.47
10.2
6.7
mmol/mol
45.0
41.4
9.46
559
6090
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
82
540
1.57
3.47
3.6
3.8
ng/l
89.1
96.1
0.38
76
458
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
31
153
2.06
3.43
1.6
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
21
89
2.39
3.33
2.0
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
142
1873
0.72
3.32
2.3
1.6
mmol/l
1.7
1.3
3.39
132
1524
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
65
2.64
3.31
2.4
3.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
15
54
2.81
3.26
1.8
1.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
712
7598
0.77
3.19
55.1
21.3
e9/l
6.7
6.9
1.57
680
7270
(3000963) Hemoglobin [Mass/volume] in Blood
712
7598
0.77
3.19
55.6
21.4
g/l
124.4
136.9
59.93
688
7395
(3026361) Erythrocytes [#/volume] in Blood
712
7597
0.77
3.18
55.1
21.2
e12/l
4.2
4.5
40.02
680
7263
(3024731) MCV [Entitic volume]
712
7596
0.77
3.17
54.9
21.2
fl
91.7
91.8
0.15
690
7393
(3035941) MCH [Entitic mass]
712
7596
0.77
3.17
54.8
21.2
pg
30.4
30.6
1.21
689
7395
(3007461) Platelets [#/volume] in Blood
712
7595
0.77
3.15
55.1
21.3
e9/l
189.4
232.4
32.79
682
7303
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
56
876
0.62
3.12
1.1
1.2
u/ml
18.2
15.6
0.08
20
318
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
61
931
0.63
3.05
1.2
1.3
iu/ml
18.6
40.2
3.77
23
281
(3008116) Ketones [Moles/volume] in Urine by Test strip
8
17
4.74
2.92
1.3
1.6
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
44
259
1.73
2.91
3.0
1.4
g/l
1.0
0.5
0.40
36
215
(3033705) Calcium.ionized [Moles/volume] in Venous blood
22
102
2.18
2.88
1.6
2.3
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
7
13
5.41
2.87
1.6
1.3
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
19
83
2.31
2.85
1.8
2.5
ml
813.2
636.9
0.88
11
57
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
13
47
2.79
2.82
1.5
1.6
umol/l
12.5
14.8
0.58
13
40
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
42
249
1.72
2.73
3.1
1.4
g/l
36.7
36.8
0.06
35
202
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
16
66
2.45
2.72
1.3
1.3
u/ml
1.4
2.7
—
7
24
(40761536) Microorganisms panel - Urine sediment
78
539
1.49
2.70
4.2
3.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
11
278
0.39
2.66
1.2
1.4
—
—
—
0
0
(3020891) Body temperature
56
361
1.58
2.65
6.6
4.9
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
22
106
2.10
2.64
1.6
2.2
mmol/l
4.2
4.1
0.56
22
106
(3035285) Chloride [Moles/volume] in Venous blood
22
106
2.10
2.64
1.6
2.2
mmol/l
107.6
105.4
1.28
22
106
(3049717) Cytology report of Urine Cyto stain
49
306
1.63
2.64
2.4
1.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
38
2.92
2.58
1.0
1.0
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
16
68
2.38
2.56
1.1
1.2
nmol/l
1.8
1.6
0.21
16
57
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
16
68
2.38
2.56
2.6
2.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
295
1.62
2.49
3.2
1.4
g/l
3.1
3.1
0.19
35
223
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
569
6162
0.82
2.47
4.8
4.1
mu/l
2.5
2.0
3.68
511
5460
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
19
89
2.16
2.46
1.8
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
20
96
2.11
2.44
6.0
3.8
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
15
64
2.36
2.39
1.4
1.3
u/ml
2.3
8.2
—
10
33
(1761482) Bacteria [#/volume] in Urine by Culture
36
213
1.72
2.39
3.6
3.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
35
2.88
2.31
1.7
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
11
41
2.70
2.28
1.1
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
11
41
2.70
2.28
1.1
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
81
585
1.42
2.26
3.0
2.3
ug/g
169.6
172.9
0.04
62
453
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
49
319
1.56
2.26
3.1
1.4
g/l
7.6
7.5
0.17
35
227
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
36
2.80
2.20
1.7
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
42
2.64
2.19
1.0
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
46
298
1.57
2.17
2.9
1.4
g/l
13.0
10.8
1.71
36
244
(3020191) Ethanol [Moles/volume] in Serum or Plasma
13
55
2.38
2.12
1.8
1.3
promille
0.7
1.2
0.64
13
44
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
25
3.22
2.09
3.8
2.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
694
7326
0.82
2.09
32.6
9.2
u/l
41.9
26.4
33.51
678
6955
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
298
2591
1.22
2.08
3.1
2.2
nmol/l
72.4
76.6
1.49
271
2207
(40768793) Breast Pathology biopsy report
7
20
3.52
2.05
1.3
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
319
1.53
2.05
3.1
1.4
g/l
4.2
3.9
0.92
35
220
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
48
319
1.53
2.05
3.1
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
204
1709
1.24
2.02
4.1
3.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
44
2.52
2.01
2.6
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
18
336
0.53
2.00
1.5
1.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
31
186
1.69
1.99
2.1
2.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
23
126
1.85
1.99
1.3
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
51
2.37
1.95
1.1
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
47
315
1.52
1.94
1.4
1.5
u/ml
4.5
40.2
—
6
7
(3009871) Measles virus Ab [Titer] in Serum
6
16
3.77
1.93
1.7
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
13
58
2.26
1.91
1.3
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
33
204
1.64
1.91
3.0
3.1
kpa
8.3
7.8
1.00
28
187
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
442
4830
0.85
1.86
4.1
3.3
pmol/l
14.6
15.1
3.94
397
4266
(3000093) Morphology [Interpretation] in Blood Narrative
16
80
2.02
1.80
1.2
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
7
23
3.06
1.80
1.6
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
7
23
3.06
1.80
1.6
1.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
14
67
2.11
1.76
2.1
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
41
2.45
1.76
1.7
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
14
269
0.51
1.73
1.9
1.3
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
24
2.93
1.72
1.3
1.8
ug/l
37.7
62.6
—
7
24
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
38
251
1.53
1.70
1.7
1.6
—
158.2
—
0
11
(3023103) Potassium [Moles/volume] in Serum or Plasma
706
7396
0.84
1.69
46.2
18.3
mmol/l
4.0
4.0
0.90
683
7144
(3034426) Prothrombin time (PT)
6
19
3.17
1.66
1.5
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
19
3.17
1.66
1.5
1.2
ug/l
11.7
9.2
—
6
19
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
40
269
1.51
1.66
2.0
3.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
369
3328
1.17
1.65
4.4
3.5
estimate
0.0
0.0
0.00
77
580
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
54
387
1.42
1.63
2.5
2.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
14
3.58
1.61
1.2
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
5
14
3.58
1.61
2.2
1.1
—
—
—
0
0
(4062490)
12
56
2.16
1.61
1.6
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
12
56
2.16
1.61
1.3
1.2
—
—
—
0
0
(3000492) Spirometry study
72
544
1.35
1.60
1.2
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
23
136
1.71
1.60
1.3
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
15
77
1.96
1.59
1.1
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
367
3317
1.17
1.59
5.9
4.7
estimate
0.0
0.0
0.00
74
582
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
20
3.01
1.58
1.2
1.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
706
7382
0.84
1.58
46.0
18.2
mmol/l
138.1
139.7
39.32
686
7136
(4268621)
11
50
2.21
1.57
2.5
2.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
36
240
1.52
1.56
3.5
3.2
mmol/l
22.1
25.0
2.54
29
208
(3043409) Potassium [Moles/volume] in Arterial blood
39
265
1.49
1.55
5.9
4.9
mmol/l
4.0
4.0
0.07
39
246
(3000330) Specific gravity of Urine by Test strip
54
391
1.40
1.55
3.6
3.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
12
57
2.12
1.55
1.3
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
12
57
2.12
1.55
1.3
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
74
954
0.76
1.51
4.0
4.9
%
32.1
32.4
0.06
55
613
(3021901) Oxygen saturation in Capillary blood
27
170
1.60
1.50
3.3
2.8
—
—
—
0
0
(3019225) pH of Specimen
92
728
1.29
1.49
3.0
3.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
12
58
2.08
1.49
1.3
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
12
58
2.08
1.49
1.3
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
349
3155
1.16
1.49
4.5
4.2
ng/l
30.7
79.0
2.38
295
2435
(3009343) pH of Capillary blood
71
545
1.33
1.44
2.9
3.5
ph
7.4
7.4
—
8
65
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
22
2.74
1.43
1.0
1.0
miu/ml
1620.3
1567.4
—
6
22
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
37
254
1.47
1.42
1.6
1.7
u/l
47.2
38.1
1.12
27
206
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
36
246
1.48
1.42
3.7
3.1
pmol/l
4.1
4.4
0.84
31
214
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
68
521
1.33
1.40
2.9
3.4
mmol/l
0.8
1.9
1.60
40
380
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
224
0.53
1.39
1.4
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
288
3200
0.86
1.39
2.6
2.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
13
67
1.95
1.38
3.4
3.1
%
62.4
55.2
—
7
39
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
12
60
2.01
1.38
1.2
1.2
%
104.0
109.6
0.19
12
52
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
223
0.53
1.38
1.4
1.5
—
—
—
0
0
(3004451) EKG impression Narrative
9
41
2.21
1.37
1.1
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
609
6413
0.87
1.37
38.2
13.7
ml/min/173m2
76.1
73.7
1.69
552
5179
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(4211845)
0
39
0.00
1.34
0.0
2.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
27
176
1.55
1.32
1.4
1.2
—
—
—
0
0
(4010399)
38
531
0.70
1.32
1.4
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
18
2.79
1.28
1.2
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
18
2.79
1.28
1.2
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
18
2.79
1.28
1.6
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
18
2.79
1.28
1.2
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
368
3371
1.15
1.28
4.4
3.5
estimate
0.0
0.0
0.00
67
562
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
11
55
2.01
1.27
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
27
178
1.53
1.27
1.2
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
35
2.30
1.27
1.5
1.9
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
71
557
1.30
1.26
3.0
3.5
kpa
4.8
5.2
3.37
59
506
(3014765) Yersinia sp identified in Stool by Organism specific culture
27
180
1.51
1.22
1.2
1.1
—
—
—
0
0
(4034850)
17
275
0.61
1.21
20.9
11.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
11
198
0.55
1.16
1.5
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
188
1650
1.17
1.16
3.9
3.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
34
0.00
1.16
0.0
2.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
55
422
1.32
1.16
3.3
2.5
e6/l
0.6
0.3
0.40
55
414
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
110
1.65
1.16
1.6
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
87
1.74
1.15
1.5
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
16
95
1.70
1.14
2.6
2.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
73
1.79
1.11
1.2
1.2
nmol/l
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
21
2.39
1.09
1.4
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
8
41
1.96
1.09
1.1
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
16
97
1.66
1.07
1.5
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
42
314
1.35
1.06
1.7
1.7
—
—
—
0
0
(44806420)
7
33
2.13
1.05
3.0
2.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
22
2.28
1.03
1.0
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
14
227
0.61
1.03
1.1
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
7
34
2.07
1.03
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
26
182
1.44
0.96
1.2
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
74
608
1.23
0.94
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
25
175
1.44
0.93
1.7
1.6
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
23
160
1.45
0.89
1.1
1.3
nmol/l
0.6
0.8
1.25
17
134
(44790048)
12
71
1.70
0.89
1.3
1.5
—
—
—
0
0
(44790047)
12
71
1.70
0.89
1.3
1.5
—
—
—
0
0
(44806118)
12
71
1.70
0.89
1.3
1.5
—
—
—
0
0
(44790049)
12
71
1.70
0.89
1.3
1.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
197
1773
1.14
0.88
1.9
1.7
pmol/l
441.9
17103861.3
1.26
160
1450
(3012565) Volume of 24 hour Urine
6
30
2.01
0.87
1.7
2.1
ml
1621.7
2095.6
—
6
25
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
101
865
1.19
0.86
2.5
2.6
ug/l
6.7
7.7
0.23
84
751
(40768443) Skin Pathology biopsy report
32
239
1.35
0.85
1.2
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
574
5499
1.11
0.83
50.6
17.5
%
15.1
13.8
54.02
566
5329
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
11
65
1.70
0.82
1.3
1.1
—
—
—
0
0
(1002224) Polysomnography panel
11
177
0.62
0.82
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
73
1.65
0.82
1.2
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
354
3315
1.11
0.80
2.1
2.1
pmol/l
83.6
91.1
2.40
177
1764
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
37
286
1.31
0.79
1.6
1.6
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
27
0.00
0.77
0.0
1.0
—
2.2
—
0
9
(3009542) Hematocrit [Volume Fraction] of Blood
617
5944
1.10
0.77
41.6
16.3
%
36.4
39.6
13.00
415
3648
(40761511) CBC panel - Blood by Automated count
690
7107
0.90
0.77
35.4
14.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
6
34
1.77
0.76
1.7
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
13
83
1.57
0.75
1.4
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
60
1.67
0.72
1.7
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
26
1.93
0.70
1.0
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
26
1.93
0.70
1.0
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
41
1.71
0.70
1.4
1.1
—
—
—
0
0
(4306422)
11
69
1.60
0.68
1.5
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
27
1.86
0.68
1.6
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
27
1.86
0.68
1.8
1.1
iu/ml
791.6
226.3
—
5
27
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
705
6863
1.10
0.64
38.6
14.8
mg/l
31.9
27.4
3.07
676
5433
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
29
1.73
0.64
1.6
1.4
u/l
236.2
205.4
—
5
29
(3029937) Albumin [Presence] in Urine by Test strip
203
1870
1.11
0.63
4.9
3.7
estimate
0.0
0.0
0.50
62
545
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
276
2582
1.10
0.63
4.7
3.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
12
79
1.53
0.62
1.3
1.2
nmol/l
2.0
0.6
0.50
12
74
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.2
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
152
0.65
0.61
2.2
1.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
20
0.00
0.60
0.0
5.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
207
0.72
0.57
1.1
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
33
266
1.25
0.56
1.2
1.2
iu/ml
34.8
117.6
—
8
104
(3006653) Thiamine [Moles/volume] in Blood
6
37
1.63
0.55
1.0
1.2
nmol/l
110.3
139.4
—
6
37
(3013512) EKG study
247
2314
1.09
0.55
4.7
4.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
264
2482
1.09
0.54
2.0
2.2
u/l
210.5
282.3
0.74
250
2304
(3044889) 12 lead EKG panel
529
5110
1.08
0.54
5.1
4.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
62
1.46
0.53
1.3
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
91
1.43
0.53
1.8
1.4
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
66
1.52
0.52
1.2
1.2
—
—
—
0
0
(3011648) Oxygen content in Venous blood
9
64
1.41
0.51
1.9
2.0
%
10.4
10.7
—
9
64
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
9
64
1.41
0.51
1.1
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
10
67
1.50
0.49
1.4
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
46
1.53
0.48
2.0
2.9
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
11
76
1.45
0.48
1.1
1.2
mu/l
342.4
91.9
0.39
11
67
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
92
1021
0.89
0.47
15.8
7.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
50
1.40
0.45
2.4
2.7
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
10
69
1.45
0.44
1.0
1.4
pmol/l
570.2
260.9
—
10
50
(3004716) Salmonella sp identified in Stool by Organism specific culture
28
229
1.23
0.44
1.4
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
95
0.63
0.42
1.2
1.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
548
5626
0.94
0.41
49.9
19.5
g/l
331.6
332.9
2.46
539
5557
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.9
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
0
15
0.00
0.41
0.0
1.1
—
15.0
—
0
9
(4146454)
14
105
1.34
0.41
2.3
2.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
16
205
0.78
0.40
1.4
1.5
e6/l
26710.9
15911.7
—
10
150
(3022313) Gas panel - Capillary blood
46
400
1.16
0.39
2.5
3.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
66
1.37
0.38
1.3
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
68
1.33
0.37
1.0
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
6
43
1.40
0.35
1.2
1.7
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
150
1595
0.93
0.34
5.7
3.8
kg/l
1.0
1.0
1.72
34
251
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
18
145
1.25
0.34
1.6
1.1
u/l
58.1
21.6
0.72
18
128
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
45
1.34
0.33
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
45
1.34
0.33
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
45
1.34
0.33
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
15
186
0.80
0.31
1.2
1.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
54
1.30
0.30
2.1
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
185
0.81
0.30
1.1
1.8
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
141
0.78
0.29
1.0
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
57
1.23
0.29
1.6
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
57
1.23
0.29
1.1
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
57
1.23
0.29
1.1
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
57
1.23
0.29
1.1
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
111
0.72
0.28
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
112
1.25
0.28
1.4
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
67
1.20
0.26
1.1
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
6
85
0.70
0.24
1.2
1.8
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
13.2
—
0
11
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
11
0.00
0.21
0.0
2.5
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.3
—
16.1
—
0
5
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
10
0.00
0.21
0.0
2.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
15
127
1.18
0.19
1.1
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
36
329
1.10
0.18
2.2
3.8
mmol/l
23.3
24.7
2.24
31
300
(3016018) Differential panel - Cerebral spinal fluid
7
60
1.17
0.18
1.1
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
14
119
1.18
0.17
1.3
1.3
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
7
61
1.15
0.17
1.7
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
68
1.18
0.16
1.0
1.1
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
13
151
0.86
0.16
1.3
1.3
e6/l
0.5
55.6
—
8
126
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
9
80
1.13
0.15
1.0
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
515
5085
1.03
0.14
5.4
3.9
mm/h
23.4
12.8
19.71
472
4612
(3045424) Erythrocytes [Presence] in Urine
10
84
1.19
0.14
1.4
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
45
424
1.06
0.12
1.6
3.1
e9/l
4.5
4.3
0.13
35
292
(3045414) Leukocytes [Presence] in Urine
29
271
1.07
0.10
1.9
1.7
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
18
164
1.10
0.09
1.5
2.0
pmol/l
207.4
217.4
0.22
18
152
(3051593) INR in Capillary blood by Coagulation assay
5
60
0.83
0.08
18.0
15.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
24
224
1.07
0.08
1.2
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
7
65
1.08
0.08
2.1
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
7
66
1.06
0.08
2.1
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
7
66
1.06
0.08
2.1
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
7
68
1.03
0.08
2.1
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
7
68
1.03
0.08
2.1
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
84
1.07
0.07
3.8
4.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
14
128
1.10
0.06
1.3
1.4
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
9
101
0.89
0.06
1.6
1.1
—
44.4
—
0
7
(3044927) Protein electrophoresis panel - Urine
9
105
0.86
0.06
1.6
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
64
659
0.97
0.06
4.0
2.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
198
1953
1.02
0.06
1.8
1.6
nmol/l
16.8
19.8
2.60
174
1637
(3023419) Bacteria identified in Sputum by Culture
13
120
1.08
0.05
2.0
2.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
59
575
1.03
0.04
2.5
2.2
nmol/l
13.4
15.0
0.53
47
499
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
128
0.94
0.02
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
37
379
0.98
0.02
1.2
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
48
486
0.99
0.00
3.4
2.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
41
406
1.01
0.00
1.2
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
16
158
1.01
0.00
1.9
1.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
141
0.99
0.00
1.1
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
115
0.96
0.00
1.1
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
57
0.88
0.00
2.0
1.6
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025315) Body weight
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
5
55
0.91
0.00
1.0
1.4
—
58.0
—
0
5
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
16
160
1.00
0.00
1.4
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
2.0
—
2.2
—
0
6
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.0
—
0
5
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
63
0.95
0.00
1.2
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
6
59
1.02
0.00
1.0
1.4
—
58.8
—
0
8
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
6
0.00
0.00
0.0
21.7
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
5.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
55
0.91
0.00
1.2
1.6
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
24.5
—
0
6
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
90
1.00
0.00
1.7
1.5
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013762) Body weight Measured
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
400.6
—
0
8
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
6.4
—
8.3
—
0
9
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_HEPATOCELLU_CARC_EXALLC – Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

GWS hits: 3

This endpoint is excluded (different definition than used in FinnGen).